1921
Volume 74, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

A person diagnosed with acquired immunodeficiency syndrome in 2000 and who received highly active antiretroviral therapy developed co-infection with dengue virus in 2003. In the course of the co-infection, he developed fever, thrombocytopenia (13,700 cells/mm), petechia, and hypoalbuminemia, which are compatible with the World Health Organization criteria for a case of dengue hemorrhagic fever. Human immunodeficiency virus was not detected 30 days before co-infection and 10 days afterwards. His CD4 cell count did not show significant alterations in the two periods evaluated. He continued his course of treatment without arterial hypotension, serious hemorrhage, or other life-threatening complications.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.2006.74.905
2006-05-01
2017-11-20
Loading full text...

Full text loading...

/deliver/fulltext/14761645/74/5/0740905.html?itemId=/content/journals/10.4269/ajtmh.2006.74.905&mimeType=html&fmt=ahah

References

  1. Morgado MG, Barcellos C, Pina MF, Bastos FI, 2000. Human immunodeficiency virus/acquired immunodeficiency syndrome and tropical diseases: a Brazilian perspective. Mem Inst Oswaldo Cruz 95 : 145–151.
  2. Hoffman IF, Jere CS, Taylor TE, Munthali P, Dyer JR, Wirima JJ, Rogerson SJ, Kumwenda N, Eron JJ, Fiscus AS, Chakraborty H, Taha TE, Cohen MS, Molyneux ME, 1999. The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentration. AIDS 13 : 487–494.
  3. Alvar J, Cañavate C, Gutiérrez-Solar B, Jiménez M, Laguna F, López-Veléz R, Molina R, Moreno J, 1997. Leishmania and human immunodeficiency virus coinfection: the first 10 years. Clin Microbiol Rev 10 : 298–319.
  4. Rocha A, de Meneses AC, da Silva AM, Ferreira MS, Nishioka SA, Burgarelli MK, Almeida E, Turcato Junior G, Metze K, Lopes ER, 1994. Pathology of patients with Chagas’ disease and acquired immunodeficiency syndrome. Am J Trop Med Hyg 50 : 261–268.
  5. Centers for Disease Control and Prevention, 1992. Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 41 : 1–19.
  6. WHO, 1997. Dengue Haemorrhagic Fever: Diagnosis, Treatment, Prevention and Control. Geneva: Word Health Organization.
  7. WHO, 1999. Guidelines for Treatment of Dengue Fever/Dengue Haemorrhagic Fever in Small Hospitals. New Delhi: World Health Organization Regional office for South-East Asia.
  8. Mole L, Ripich S, Margolis D, Holodniy M, 1997. The impact of active herpes simplex virus infection on human immunodeficiency virus load. J Infect Dis 176 : 766–770.
  9. Halstead SB, 1988. Pathogenesis of dengue: challenges to molecular biology. Science 239 : 476–481.
  10. Sulkowsky MS, Chaisson RE, Karp CL, Moore RD, Margolick JB, Quinn TC, 1998. The effect of acute infectious illnesses on plasma human immunodeficiency virus (HIV) type 1 load and the expression of serologic markers of immune activation among HIV-infected adults. J Infect Dis 178 : 1642–1648.
  11. Watt G, Kantipong P, Jongsakul K, 2003. Decrease in human immunodeficiency virus type 1 load during acute dengue fever. Clin Infect Dis 36 : 1067–1069.
  12. Watt G, Kantipong P, Sousa M, Chanbancherd P, Jongsakul K, Ruangweerayud R, Loomis-Price LD, Polonis V, Myint KS, Birx DL, Brown AE, Krishna S, 2000. HIV-1 suppression during acute scrub-typhus infection. Lancet 356 : 475–479.
  13. Watt G, Kantipong P, Jongsakul K, Sousa M, Burnouf T, 2001. Passive transfer of scrub typhus plasma to patients with AIDS: a descriptive clinical study. Q J Med 94 : 599–607.
  14. Moss WJ, Ryon JJ, Monze M, Cutts F, Quinn TC, Griffin DE, 2002. Suppression of human immunodeficiency virus replication during acute measles. J Infect Dis 185 : 1035–1042.
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2006.74.905
Loading
/content/journals/10.4269/ajtmh.2006.74.905
Loading

Data & Media loading...

  • Received : 18 May 2005
  • Accepted : 07 Jan 2006

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error